中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

Protective effect of pinocembrin in a mouse model of liver injury induced by acetaminophen

DOI: 10.3969/j.issn.1001-5256.2020.03.027
Research funding:

 

  • Received Date: 2019-12-12
  • Published Date: 2020-03-20
  • Objective To investigate the protective effect of pinocembrin( PIN) in a mouse model of liver injury induced by acetaminophen( APAP). Methods A total of 50 healthy male C57BL/6 J mice were randomly divided into blank group,PIN( 50 mg/kg) group,APAP( 300 mg/kg) model group,PIN( 30 mg/kg) + APAP( 300 mg/kg) experimental group,and PIN( 50 mg/kg) + APAP( 300 mg/kg) experimental group,with 10 mice in each group. The mice in the blank group and the model group were given an equal volume of normal saline by gavage,and those in the PIN group and the PIN + APAP groups were given PIN by gavage once a day,for 7 consecutive days. At 2 hours after the last administration,the mice in the model group and the PIN + APAP groups were given intraperitoneal injection of APAP 300 mg/kg once,and those in the blank group and the PIN group were given intraperitoneal injection of an equal volume of normal saline. Serum samples were collected to measure the levels of alanine aminotransferase( ALT) and aspartate aminotransferase( AST); liver tissue homogenate was prepared to measure the biochemical parameters of malondialdehyde( MDA),superoxide dismutase( SOD),and glutathione( GSH);HE staining was used to observe liver histopathology. A one-way analysis of variance was used for comparison of continuous data between multiple groups,and the least significant difference t-test was used for further comparison between two groups. Results Compared with the blank group,the APAP( 300 mg/kg) model group had significant increases in the activities of ALT and AST( P < 0. 01),suggesting that a model was successfully established,while the PIN( 30 mg/kg) + APAP( 300 mg/kg) group and the PIN( 50 mg/kg) + APAP( 300 mg/kg) group had significant reductions in the levels of ALT and AST( P < 0. 01). Compared with the blank group,the APAP( 300 mg/kg)model group had a significant increase in the level of MDA and significant reductions in SOD activity and GSH level in the liver( P < 0. 01);compared with the APAP( 300 mg/kg) model group,the PIN( 30 mg/kg) + APAP( 300 mg/kg) group and the PIN( 50 mg/kg) + APAP( 300 mg/kg) group had a significant reduction in the level of MDA and significant increases in SOD activity and GSH level in the liver( P <0. 05). Histopathological observation showed that PIN significantly improved liver injury caused by APAP and helped to maintain normal liver histomorphology. Conclusion PIN exerts a marked protective effect on liver injury induced by APAP,possibly by inhibiting oxidative stress in the liver.

     

  • [1] VUPPALANCHI R,LIANGPUNSAKUL S,CHALASANI N. Etiology of new-onset jaundice:How often is it caused by idiosyncratic drug-induced liver injury in the United States?[J].Am J Gastroenterol,2007,102(3):558-562; quiz 693.
    [2] CHAYANUPATKUL M,SCHIANO TD. Acute liver failure secondary to drug-induced liver injury[J]. Clin Liver Dis,2020,24(1):75-87.
    [3] JAESCHKE H,MCGILL MR,RAMACHANDRAN A. Oxidant stress,mitochondria,and cell death mechanisms in drug-induced liver injury:Lessons learned from acetaminophen hepatotoxicity[J]. Drug Metab Rev,2012,44(1):88-106.
    [4] ZHANG TT,XU XL,JIANG MH,et al. Hepatoprotective function of Penthorum Chinense Pursh[J]. Food Funct,2013,4(11):1581-1585.
    [5] ZHANG X,MENG CW,HE YC,et al. Study on Flavonoids of Penthorum Chinense[J]. Chin Tradit Herb Drug,2017,48(1):31-35.(in Chinese)张潇,蒙春旺,何亚聪,等.赶黄草黄酮类化学成分研究[J].中草药,2017,48(1):31-35.
    [6] ZHOU F,WANG A,LI D,et al. Pinocembrin from Penthorum chinense Pursh suppresses hepatic stellate cells activation through a unified SIRT3-TGF-β-Smad signaling pathway[J]. Toxicol Appl Pharmacol,2018,341:38-50.
    [7] ZHANG HW,ZHANG L. Research progress on pinocembrin:Potential therapeutic applications and action mechanisms[J]. Acta Neuropharmacologica,2016,6(5):45-52.(in Chinese)张海威,张力.乔松素临床应用和作用机制的研究进展[J].神经药理学报,2016,6(5):45-52.
    [8] QI J,ZHOU Z,LIM CW,et al. Amlexanox ameliorates acetaminophen-induced acute liver injury by reducing oxidative stress in mice[J]. Toxicol Appl Pharmacol,2019,385:114767.
    [9] YOON E,BABAR A,CHOUDHARY M,et al. Acetaminophen-induced hepatotoxicity:A comprehensive update[J]. J Clin Transl Hepatol,2016,4(2):131-142.
    [10] YAN M,HUO Y,YIN S,et al. Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions[J]. Redox Biol,2018,17:274-283.
    [11] JIANG H,BAI XF. Research advances in acute liver failure[J]. J Clin Hepatol,2018,34(9):1824-1831.(in Chinese)姜泓,白雪帆.急性肝衰竭研究进展[J].临床肝胆病杂志,2018,34(9):1824-1831.
    [12] YU PF,WU Q,DUAN ZP,et al. Research advances in the mechanism of drug-induced liver injury due to paracetamol[J]. J Clin Hepatol,2019,35(9):2108-2112.(in Chinese)余朋飞,吴桥,段钟平,等.对乙酰氨基酚致药物性肝损伤的机制研究进展[J].临床肝胆病杂志,2019,35(9):2108-2112.
    [13] KON K,KIM JS,JAESCHKE H,et al. Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes[J]. Hepatology,2004,40(5):1170-1179.
    [14] SAAD MA,ABDEL SALAM RM,KENAWY SA,et al. Pinocembrin attenuates hippocampal inflammation,oxidative perturbations and apoptosis in a rat model of global cerebral ischemia reperfusion[J]. Pharmacol Rep,2015,67(1):115-122.
    [15] PROMSAN S,JAIKUMKAO K,PONGCHAIDECHA A,et al.Pinocembrin attenuates gentamicin-induced nephrotoxicity in rats[J]. Can J Physiol Pharmacol,2016,94(8):808-818.
    [16] FAN L,XIE XX,CHEN L,et al. Protective effects of three Penthorum Chinense extracts on endotoxin-induced liver injury in mice[J]. Chin Tradit Patent Med,2019,41(2):291-297.(in Chinese)范玲,谢星星,陈立,等.赶黄草3种提取物对小鼠内毒素性肝损伤的保护作用[J].中成药,2019,41(2):291-297.
    [17] PUNVITTAYAGUL C,WONGPOOMCHAI R,TAYA S,et al.Effect of pinocembrin isolated from Boesenbergia pandurata on xenobiotic-metabolizing enzymes in rat liver[J]. Drug Metab Lett,2011,5(1):1-5.
  • Relative Articles

    [1]Development Committee of Clinical Practice Guidelines for Robotic Hepatopancreatobiliary Surgery. Clinical practice guidelines for robotic hepatopancreatobiliary surgery[J]. Journal of Clinical Hepatology, 2019, 35(7): 1459-1471. doi: 10.3969/j.issn.1001-5256.2019.07.009
    [2]Development Committee of Clinical Practice Guidelines for Laparoscopic Hepatopancreatobiliary Surgery. Clinical practice guidelines for laparoscopic hepatopancreatobiliary surgery[J]. Journal of Clinical Hepatology, 2019, 35(7): 1450-1458. doi: 10.3969/j.issn.1001-5256.2019.07.008
    [3]Xu YanLing, Zhao Xu, Guo XiaoLin, Ji HuiFan, Zhang Ying, Song XinYue, Wang JingYu, Sun XiaoFeng, Liu Kai, He RongHua, Gao PuJun. Clonorchiasis complicated by multiple cholelithiasis and cholestatic cirrhosis misdiagnosed as Budd-Chiari syndrome: A case report[J]. Journal of Clinical Hepatology, 2018, 34(7): 1514-1516. doi: 10.3969/j.issn.1001-5256.2018.07.029
    [4]Zhao GuoPing, Hu JianPing, Wang JiRong. Clinical experience in choledochoscopy for the treatment of intrahepatic bile duct stones complicated by biliary stricture:a clinical analysis of 230 cases[J]. Journal of Clinical Hepatology, 2017, 33(11): 2166-2169. doi: 10.3969/j.issn.1001-5256.2017.11.023
    [5]Jiang Chao, Wang HaiJiu, Ren Li, Yang DanCaiRang, Hou LiChao, Zhou Ying, Wen Hao, Fan HaiNing. Application status of three- dimensional CT reconstruction in hepatobiliary surgery[J]. Journal of Clinical Hepatology, 2017, 33(2): 389-393. doi: 10.3969/j.issn.1001-5256.2017.02.041
    [6]Lu Xia, Jia HaiMing, Mi TaiYu, Zhang WenQuan, Gao Peng. Effect of fast track surgery on anxiety index and stress indices in patients undergoing laparoscopic cholecystectomy[J]. Journal of Clinical Hepatology, 2017, 33(2): 308-312. doi: 10.3969/j.issn.1001-5256.2017.02.022
    [7]Wu Xiao, Xia Hao, Wu Jian, Zhang Ming. Clinical experience in treatment of complex intrahepatic bile duct stones by regular hepatectomy[J]. Journal of Clinical Hepatology, 2016, 32(9): 1756-1759. doi: 10.3969/j.issn.1001-5256.2016.09.025
    [8]Wu ErBin, Zhang JinWei. Clinical application of selective intraoperative cholangiography in biliary system surgery[J]. Journal of Clinical Hepatology, 2016, 32(7): 1357-1359. doi: 10.3969/j.issn.1001-5256.2016.07.031
    [9]Chen ZhiYu, Bie Ping. Clinical application of combined vascular resection and reconstruction in surgical treatment of hilar cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2016, 32(7): 1277-1279. doi: 10.3969/j.issn.1001-5256.2016.07.011
    [10]Han Wei, Yue Qing, Yan JingZhe, Jia BaoXing, Wang YingChao, Liu YaHui. Concept of fast-track surgery and its application in perioperative period of hepatectomy for liver cancer[J]. Journal of Clinical Hepatology, 2016, 32(10): 2007-2011. doi: 10.3969/j.issn.1001-5256.2016.10.044
    [11]Qi WenLei, Zhang RuoYan, Chai WenGang, Liu MingJiang, Du XiaoHong, Ye JunFeng. Diagnosis of clonorchiasis during and after biliary tract surgery: a clinical analysis of 15 cases[J]. Journal of Clinical Hepatology, 2016, 32(11): 2134-2137. doi: 10.3969/j.issn.1001-5256.2016.11.026
    [12]Cheng XiangChao, Yuan QiDong, Zhao JianHong, Liu Bin. Percutaneous transhepatic approach for intrahepatic and extrahepatic bile duct stones: a clinical analysis of 19 cases[J]. Journal of Clinical Hepatology, 2015, 31(10): 1685-1687. doi: 10.3969/j.issn.1001-5256.2015.10.031
    [13]Zhang HaoYu, Liu Bin. Research advances in surgical treatment of intrahepatic bile duct stones[J]. Journal of Clinical Hepatology, 2015, 31(10): 1726-1729. doi: 10.3969/j.issn.1001-5256.2015.10.046
    [14]Li QiNan, Zhang YuHuai, Geng Jie. Safety and efficacy of fast-track surgery in perioperative nursing for biliary calculi surgery: a meta-analysis[J]. Journal of Clinical Hepatology, 2015, 31(10): 1660-1664. doi: 10.3969/j.issn.1001-5256.2015.10.025
    [15]Xing TongChao, Ren Bin, Wang YuPeng, Yang DongXing. Clinical effect of choledochofiberscope-assisted secondary surgery in treatment of intrahepatic and extrahepatic biliary stones[J]. Journal of Clinical Hepatology, 2015, 31(8): 1325-1327. doi: 10.3969/j.issn.1001-5256.2015.08.036
    [16]Li Jiang, Liu Bin. More attention to initial surgical treatment of hepatolithiasis[J]. Journal of Clinical Hepatology, 2015, 31(10): 1612-1614. doi: 10.3969/j.issn.1001-5256.2015.10.012
    [17]Tang CaiXi, Zhao ZhiJian, Feng Bin, Yang KaiQing. Surgical treatment of cholangiolithiasis with cavernous transformation of the portal vein: a review and analysis of 18 cases[J]. Journal of Clinical Hepatology, 2014, 30(1): 39-41. doi: 10.3969/j.issn.1001-5256.2014.01.013
    [18]Lu: WenPing. Clinical classification of hepatolithiasis and choice of surgical strategy[J]. Journal of Clinical Hepatology, 2013, 29(6): 404-406+410.
    [19]Wu LiMing, Cheng CaiTao, Wang JiangHua, Chen XianXiang. Clinical effect of laparoscopic reoperation combined with choledochoscope in treatment of intra-and extrahepatic bile duct stones:analysis of 35 cases[J]. Journal of Clinical Hepatology, 2013, 29(7): 516-519. doi: 1001-5256 (2013) 07-0516-04
    [20]Ou Xi, Xiong Pei, Ye JianYu, Liu JiKui. Application of medical obturation glue in the treatment of hepatolithiasis with laparoscopic hepatectomy[J]. Journal of Clinical Hepatology, 2011, 27(9): 927-930.
  • Cited by

    Periodical cited type(13)

    1. 路燕,陈明月,郑秀良,雷宇. 185例药物性肝损伤患者的临床特征分析. 安徽医学. 2022(03): 308-313 .
    2. 赵临潇,左博云,李静亚,于东升. 妊娠期肝内胆汁淤积症孕妇胎盘ABCB4基因表达与妊娠结局的关系. 海南医学. 2022(11): 1424-1427 .
    3. 张慧芳,王高莹,邹萍,王晶,董蕊锐,张婷,孟西娜. 妊娠期肝内胆汁淤积症血清甘胆酸水平与妊娠结局的关系. 中国临床研究. 2022(06): 793-796 .
    4. 林洪萍,黄晋萍,黄淑兰,卢君,黎春,杨佳柳. 中药外洗在妊娠期肝内胆汁淤积症诱发皮肤瘙痒患者中的应用. 中国医学创新. 2022(19): 96-99 .
    5. 李媛,郑泽玉,田阗,邬洪明,田嫣然,李茂. 妊娠期肝内胆汁淤积症的危险因素分析. 临床和实验医学杂志. 2021(02): 200-203 .
    6. 段兴平,王燕,黄常友,郑会贤,罗一,覃正文,任郁. 妊娠期肝病的临床特征及研究进展. 临床肝胆病杂志. 2020(06): 1407-1411 . 本站查看
    7. 陈韵洁,张晨,谭娟. 脂肪酸转运体蛋白FATP4、CD36、FABP1在妊娠期肝内胆汁淤积胎盘中表达研究. 中外医疗. 2020(15): 30-31+46 .
    8. 唐照青,俞海珍. 联合监护评估对妊娠期无症状高胆汁酸血症孕妇围生儿预后的价值. 中国现代药物应用. 2020(18): 19-22 .
    9. 汪学耀,张涛,荆成宝. 血清总胆汁酸与甘胆酸水平诊断妊娠期肝内胆汁淤积症能力的Meta分析. 现代检验医学杂志. 2020(05): 73-76 .
    10. 吕玉清. 我院中药处方中妊娠患者疾病及用药情况分析研究. 海峡药学. 2020(10): 176-178 .
    11. 刘燕,王丽娟,李盈盈. 综合护理在妊娠期肝内胆汁淤积症患者中的临床效果分析. 妇产与遗传(电子版). 2020(03): 40-44 .
    12. 张燕,王伟红. 妊娠期肝内胆汁淤积症孕妇血清总胆汁酸、谷草转氨酶及Th17/Treg平衡水平及临床意义. 中国计划生育学杂志. 2020(12): 2093-2097 .
    13. 马艳辉,邵久玲,王双梅. 低分子肝素治疗妊娠期肝内胆汁淤积症的疗效及对肝胆指标、母婴结局的影响. 哈尔滨医药. 2020(05): 438-440 .

    Other cited types(3)

  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 4.3 %FULLTEXT: 4.3 %META: 93.3 %META: 93.3 %PDF: 2.4 %PDF: 2.4 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 5.9 %其他: 5.9 %其他: 0.3 %其他: 0.3 %India: 0.3 %India: 0.3 %[]: 0.3 %[]: 0.3 %上海: 1.6 %上海: 1.6 %东莞: 0.3 %东莞: 0.3 %北京: 5.6 %北京: 5.6 %南宁: 1.3 %南宁: 1.3 %台州: 3.2 %台州: 3.2 %吉林: 1.1 %吉林: 1.1 %哥伦布: 0.3 %哥伦布: 0.3 %宁波: 0.3 %宁波: 0.3 %张家口: 3.5 %张家口: 3.5 %扬州: 0.3 %扬州: 0.3 %昆明: 0.3 %昆明: 0.3 %杭州: 1.6 %杭州: 1.6 %湖州: 2.1 %湖州: 2.1 %芒廷维尤: 33.0 %芒廷维尤: 33.0 %芝加哥: 0.3 %芝加哥: 0.3 %莫斯科: 1.3 %莫斯科: 1.3 %萨斯卡通: 0.3 %萨斯卡通: 0.3 %衢州: 1.9 %衢州: 1.9 %西宁: 32.2 %西宁: 32.2 %重庆: 0.3 %重庆: 0.3 %金华: 0.8 %金华: 0.8 %铜陵: 0.3 %铜陵: 0.3 %长春: 1.1 %长春: 1.1 %长沙: 0.5 %长沙: 0.5 %其他其他India[]上海东莞北京南宁台州吉林哥伦布宁波张家口扬州昆明杭州湖州芒廷维尤芝加哥莫斯科萨斯卡通衢州西宁重庆金华铜陵长春长沙

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1455) PDF downloads(226) Cited by(16)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return